MedPath

Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

Not Applicable
Completed
Conditions
Major Depressive Disorder
Interventions
Other: MoodGYM
Registration Number
NCT01851967
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese Americans in the Boston area.

Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules.

Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking.

Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
112
Inclusion Criteria
  • Resident of the US, but self-identified as Chinese origin
  • At least 18 years of age
  • Proficiency in Chinese, including the ability to read Chinese
  • Access to computer and internet
  • Scores > 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)
Exclusion Criteria
  • Current ongoing psychiatric or psychological treatment
  • Using illicit drugs or consumption > 3 standard drinks in a day
  • Currently experiencing a psychotic illness
  • Past or current history of schizophrenia or bipolar disorder
  • ECT during the last year
  • Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MoodGYMMoodGYMThis study is a single-arm intervnetion. All subjects will be assigned to receive six weeks of online CBT through MoodGYM.
Primary Outcome Measures
NameTimeMethod
Change in Center for Epidemiologic Studies Depression Scale (CES-D)Weeks 0, 6 (pre/post)

The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Massachusetts General Hospital Depression Clinical and Research Program

🇺🇸

Boston, Massachusetts, United States

Ying Wang

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath